Topic Hub

Liraglutide Generic — Regulatory History

3 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.

3articles

28keywords mapped

2026-05-26latest review

Explore

Liraglutide Generic — Regulatory History library

Showing 3 of 3 clinical reviews.

Safety2026-05-26

Liraglutide FAERS Safety Signals: What Post-Market Surveillance Data Actually Show

A clinical review of liraglutide safety signals reported through the FDA Adverse Event Reporting System (FAERS), including pancreatitis, gallbladder events, thyroid concerns, and acute kidney injury.

Read clinical review

Clinical Reviews2026-05-26

Liraglutide FDA Approval History: A Complete Regulatory Timeline

Full FDA approval history for liraglutide (Victoza, Saxenda), covering every indication, label expansion, boxed warning, post-market safety update, and generic entry from 2010 through 2025.

Read clinical review

Questions2026-05-26

Liraglutide Pipeline and Next-Gen: FDA Status, Generic Entry, and What Comes After

A clinical review of liraglutide's regulatory history, current FDA label, generic pipeline status, and next-generation GLP-1 receptor agonists positioned to follow it.

Read clinical review